Valneva SE VALN
NASDAQ VALN
$6.91 -0.15 (-2.20%)
As of: Sep 4, 2026 · 3:14 PM EDT

Valneva SE (VALN) Assets Average (2022 - 2026)

Valneva SE (VALN) posted Assets Average of $449.9 million for Q1 2026, down 8.95% sequentially from $494.1 million in Q4 2025, and down 13.61% YoY from $520.8 million in Q1 2025.

Analysis

Valneva SE (VALN) Assets Average (2022 - 2026) Analysis & Trends

Valneva SE has reported Assets Average for 5 years, with the latest figure at $449.9 million in Q1 2026.

  • Quarterly Assets Average fell 13.61% year-over-year to $449.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $449.9 million (down 13.61% YoY) and the FY2025 annual result came in at $502.7 million, down 3.21% from the prior year.
  • Assets Average fell to $449.9 million in Q1 2026 per VALN's latest filing, from $494.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $903.9 million in Q1 2022 and troughed at $449.9 million in Q1 2026.
  • A 5-year average of $596.3 million and a median of $534.9 million in 2024 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2023 and 2024: Assets Average retreated 29.91% in 2023, then advanced 3.77% in 2024.
  • Over 5 years, Assets Average stood at $668.9 million in 2022, then slipped by 20.64% to $530.8 million in 2023, then gained by 3.77% to $550.8 million in 2024, then retreated by 10.3% to $494.1 million in 2025, then dropped by 8.95% to $449.9 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $449.9 million, $494.1 million, and $529.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 3.29 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 19.82 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.09 Bn
10 Valneva SE 580.64 Mn 439.38 Mn 1.86 Mn 443.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 443.42 Mn
Mar 31, 2026 449.90 Mn
Dec 31, 2025 494.13 Mn
Sep 30, 2025 529.50 Mn
Jun 30, 2025 521.13 Mn
Mar 31, 2025 520.80 Mn
Dec 31, 2024 550.84 Mn
Sep 30, 2024 534.90 Mn
Jun 30, 2024 524.35 Mn
Mar 31, 2024 520.63 Mn
Dec 31, 2023 530.83 Mn
Sep 30, 2023 578.74 Mn
Jun 30, 2023 612.05 Mn
Mar 31, 2023 633.60 Mn
Dec 31, 2022 668.89 Mn
Sep 30, 2022 738.79 Mn
Jun 30, 2022 823.29 Mn
Mar 31, 2022 903.94 Mn